IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 225 filers reported holding IVERIC BIO INC in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $25,849,645 | -47.6% | 657,083 | -67.6% | 0.01% | -50.0% |
| Q1 2023 | $49,356,105 | +63.2% | 2,028,611 | +43.6% | 0.01% | +55.6% |
| Q4 2022 | $30,238,113 | +317.3% | 1,412,336 | +249.6% | 0.01% | +350.0% |
| Q3 2022 | $7,247,000 | +1151.6% | 403,953 | +571.3% | 0.00% | – |
| Q2 2022 | $579,000 | -94.6% | 60,175 | -90.5% | 0.00% | -100.0% |
| Q1 2022 | $10,662,000 | +1391.2% | 633,507 | +1382.4% | 0.00% | – |
| Q4 2021 | $715,000 | -97.9% | 42,734 | -98.0% | 0.00% | -100.0% |
| Q3 2021 | $34,355,000 | +16337.8% | 2,115,502 | +6276.6% | 0.01% | – |
| Q2 2021 | $209,000 | +58.3% | 33,176 | +55.9% | 0.00% | – |
| Q1 2021 | $132,000 | +0.8% | 21,282 | +12.3% | 0.00% | – |
| Q4 2020 | $131,000 | -97.9% | 18,944 | -98.3% | 0.00% | -100.0% |
| Q3 2020 | $6,176,000 | +381.4% | 1,095,080 | +335.4% | 0.00% | – |
| Q2 2020 | $1,283,000 | -57.8% | 251,510 | -71.6% | 0.00% | -100.0% |
| Q1 2020 | $3,041,000 | -63.6% | 884,155 | -9.2% | 0.00% | -66.7% |
| Q4 2019 | $8,351,000 | – | 973,324 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |